About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT01113814

Acoustic Radiation Force Impulse-Imaging in Comparison to Transient Elastography for Liver Fibrosis Staging in HCV

This study will evaluate the effectiveness of Acoustic Radiation Force Impulse (ARFI)- Imaging compared to Transient Elastography (FibroScan) in differentiating liver fibrosis in patients with chronic...

Lead sponsor: Johann Wolfgang Goethe University Hospital•9 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Johann Wolfgang Goethe University Hospital

Age

18 - 79 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Male or female, 18-79 years old
•Written consent
•Chronic Hepatitis C infection
•Liver biopsy planned or performed within the last six months
•In addition, 10 patients/center with proven liver cirrhosis without present liver biopsy can be included

Exclusion Criteria

•Consuming illness (HIV infection, malignoma)
•Comorbidities associated to HCV (HBV, NASH, hemochromatosis, primary sclerosing cholangitis, primary biliary cirrhosis
•Antiviral therapy between liver biopsy and study inclusion
•Pacemaker or heart defibrillator
•Pregnancy or lactation
•Liver transplantation

Related studies

The Efficacy of Vosevi in Treating DAA-experienced Patients

NCT06180590 · Chronic Hepatitis C, Medication Reaction

Active Not Recruiting

Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong Kong

NCT03993925 · Chronic Hepatitis C, Intravenous Drug Usage

COMPLETEDPhase 2

Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM

NCT00199719 · Chronic Hepatitis C

COMPLETEDPhase 4

Study of the Efficacy and Safety of Pegnano Plus Barivir (Ribavirin) in Treatment-naïve Patients With Chronic Hepatitis C at KienGiang General Hospital

NCT06922643 · Chronic Hepatitis C

Evaluating Safety and Efficacy In Hepatitis C Patients After PegIntron Pen Treatment (Study P04896)

NCT01340573 · Chronic Hepatitis C

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 22, 2012Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment—

Start date—

Last updatedMay 22, 2012

Condition

Chronic Hepatitis C

Locations shown

Bordeaux University Hospital

Bordeaux

Universitätsklinikum Düsseldorf

Düsseldorf

Universitätsklinikum Erlangen

Erlangen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 22, 2012Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions